---
title: "Citius Oncology (CTOR.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CTOR.US/norm.md"
symbol: "CTOR.US"
name: "Citius Oncology"
parent: "https://longbridge.com/en/quote/CTOR.US.md"
datetime: "2026-05-21T17:37:47.081Z"
locales:
  - [en](https://longbridge.com/en/quote/CTOR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CTOR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CTOR.US/norm.md)
---

# Citius Oncology (CTOR.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2700 | -0.0633 | -0.0637 | -0.0750 | -0.1081 |
| ROE | -227.23% | -42.87% | -51.74% | -63.14% | -80.44% |
| Revenue | 1.67M | 3.94M | - | - | - |
| Net income | -26.61M | -5.53M | -5.00M | -5.37M | -7.74M |
| Operating income | -28.61M | -5.25M | -4.71M | -4.94M | -7.47M |
| Gross margin | 80.27% | 79.99% | - | - | - |
| Net margin | -1595.98% | -140.31% | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 100.70M | 109.97M | 100.94M | 91.71M | 91.44M |
| Leverage | 2.86 | 1.88 | 2.25 | 2.83 | 2.57 |
| BVPS | 0.3793 | 0.6889 | 0.5372 | 0.4528 | 0.4981 |
| Turnover | 0.0584 | 0.0394 | - | - | - |
| Cash & STI | 2.63M | 7.30M | 3.92M | 112.00 | 112.00 |
| Inv & Rec | 22.66M | 22.64M | 22.29M | 17.21M | 15.34M |
| LT assets | - | - | - | - | - |
| Net debt | 1.17M | -3.50M | -124797.00 | 3.80M | 3.80M |

## Cash Flow Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.83M | -7.35M | -5.49M | 0.0000 | 0.0000 |
| Investing CF | -600000.00 | -4.40M | -5.75M | - | - |
| Financing CF | -231199.00 | 15.13M | 15.17M | - | - |
| Free CF | 3.93M | -14.17M | -15.20M | 2.02M | 2.80M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |